Approach to Patients with Stinging Insect Allergy

Elissa M. Abrams; David B.K. Golden

doi:10.1016/j.mcna.2019.08.006

Approach to Patients with Stinging Insect Allergy

Elissa M. Abrams, David B.K. Golden

Johns Hopkins Bayview Hospital

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Stinging insect allergy is uncommon but can be life threatening. Diagnosis requires clinical history and confirmative skin or blood testing by an allergist. Baseline serum tryptase level can be used to stratify risk. Treatment is supportive for all reactions except for anaphylaxis, which is treated with intramuscular epinephrine, recumbent posture, and adjunct measures such as IV fluids, and oxygen. Venom immunotherapy is most effective for long-term management in patients with a history of anaphylaxis. Venom immunotherapy rapidly reduces the risk of sting anaphylaxis by up to 98% and maintenance treatment can be stopped after 5 years in most cases.

Original language	English (US)
Pages (from-to)	129-143
Number of pages	15
Journal	Medical Clinics of North America
Volume	104
Issue number	1
DOIs	https://doi.org/10.1016/j.mcna.2019.08.006
State	Published - Jan 2020

Keywords

Anaphylaxis
Large local reaction
Stinging insect
Venom immunotherapy

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.mcna.2019.08.006

Cite this

@article{df507c84505a4a4caf6065dcce0f9872,

title = "Approach to Patients with Stinging Insect Allergy",

abstract = "Stinging insect allergy is uncommon but can be life threatening. Diagnosis requires clinical history and confirmative skin or blood testing by an allergist. Baseline serum tryptase level can be used to stratify risk. Treatment is supportive for all reactions except for anaphylaxis, which is treated with intramuscular epinephrine, recumbent posture, and adjunct measures such as IV fluids, and oxygen. Venom immunotherapy is most effective for long-term management in patients with a history of anaphylaxis. Venom immunotherapy rapidly reduces the risk of sting anaphylaxis by up to 98% and maintenance treatment can be stopped after 5 years in most cases.",

keywords = "Anaphylaxis, Large local reaction, Stinging insect, Venom immunotherapy",

author = "Abrams, {Elissa M.} and Golden, {David B.K.}",

year = "2020",

month = jan,

doi = "10.1016/j.mcna.2019.08.006",

language = "English (US)",

volume = "104",

pages = "129--143",

journal = "Medical Clinics of North America",

issn = "0025-7125",

publisher = "W.B. Saunders",

number = "1",

}

TY - JOUR

T1 - Approach to Patients with Stinging Insect Allergy

AU - Abrams, Elissa M.

AU - Golden, David B.K.

PY - 2020/1

Y1 - 2020/1

N2 - Stinging insect allergy is uncommon but can be life threatening. Diagnosis requires clinical history and confirmative skin or blood testing by an allergist. Baseline serum tryptase level can be used to stratify risk. Treatment is supportive for all reactions except for anaphylaxis, which is treated with intramuscular epinephrine, recumbent posture, and adjunct measures such as IV fluids, and oxygen. Venom immunotherapy is most effective for long-term management in patients with a history of anaphylaxis. Venom immunotherapy rapidly reduces the risk of sting anaphylaxis by up to 98% and maintenance treatment can be stopped after 5 years in most cases.

AB - Stinging insect allergy is uncommon but can be life threatening. Diagnosis requires clinical history and confirmative skin or blood testing by an allergist. Baseline serum tryptase level can be used to stratify risk. Treatment is supportive for all reactions except for anaphylaxis, which is treated with intramuscular epinephrine, recumbent posture, and adjunct measures such as IV fluids, and oxygen. Venom immunotherapy is most effective for long-term management in patients with a history of anaphylaxis. Venom immunotherapy rapidly reduces the risk of sting anaphylaxis by up to 98% and maintenance treatment can be stopped after 5 years in most cases.

KW - Anaphylaxis

KW - Large local reaction

KW - Stinging insect

KW - Venom immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=85074411334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074411334&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2019.08.006

DO - 10.1016/j.mcna.2019.08.006

M3 - Review article

C2 - 31757231

AN - SCOPUS:85074411334

SN - 0025-7125

VL - 104

SP - 129

EP - 143

JO - Medical Clinics of North America

JF - Medical Clinics of North America

IS - 1

ER -

Approach to Patients with Stinging Insect Allergy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this